Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension

The deficiency of antigen‐specific T cells and the induction of various treatment‐induced immunosuppressions still limits the clinical benefit of cancer immunotherapy. Although the chemo‐immunotherapy adjuvanted with Toll‐like receptor 7/8 agonist (TLR 7/8a) induces immunogenic cell death (ICD) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Seung Mo, Lee, Sang Nam, Kim, Jung Eun, Yoo, Yeon Jeong, Song, Chanyoung, Shin, Hong Sik, Phuengkham, Hathaichanok, Lee, Chang Hoon, Um, Soong Ho, Lim, Yong Taik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498862/
https://www.ncbi.nlm.nih.gov/pubmed/34363349
http://dx.doi.org/10.1002/advs.202102043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498862/
https://www.ncbi.nlm.nih.gov/pubmed/34363349
http://dx.doi.org/10.1002/advs.202102043

Ejemplares similares